← Back to Search

Aerosol Box Use During Cardiopulmonary Resuscitation for Cardiac Arrest and Coronavirus Protection

N/A
Waitlist Available
Led By Adam C Cheng, MD
Research Sponsored by KidSIM Simulation Program
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
CPR Provider: Basic Life Support, Adult or Pediatric Advanced Life Support certification
Airway Provider: Adult or Pediatric Advanced Life Support certification
Must not have
Unable to perform tasks required of the role due to physical limitations
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after simulated resuscitation
Awards & highlights
No Placebo-Only Group

Summary

This trial is researching how well an aerosol box protects HCWs from germs like the coronavirus when performing high-risk medical procedures.

Who is the study for?
This trial is for healthcare workers who perform CPR and other airway management procedures, such as doctors, nurses, respiratory therapists, and physician assistants. They must be certified in Advanced Life Support or Basic Life Support. Those unable to consent or with physical limitations that prevent task performance are excluded.
What is being tested?
The study tests the effectiveness of an aerosol box designed to protect healthcare workers from airborne particles during CPR on patients with COVID-19. It aims to understand particle dispersion during these procedures and improve infection control measures.
What are the potential side effects?
Since this trial involves a protective device rather than a medication, there are no direct side effects like those associated with drugs. However, potential indirect issues may include reduced accessibility or visibility while performing medical procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am certified in Basic Life Support or Advanced Life Support.
Select...
I am certified in either Adult or Pediatric Advanced Life Support.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot do certain tasks because of my physical limitations.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at 2, 4, 6, 8, and 10 minutes of simulated resuscitation.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at 2, 4, 6, 8, and 10 minutes of simulated resuscitation. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percentage of overall excellent CPR
Secondary study objectives
Area of HCP contamination (cm2) for CPR providers
CC fraction
Disease particle concentration (ppm) at head of bed and over patient torso
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Aerosol BoxExperimental Treatment1 Intervention
The team will complete the resuscitation scenario with an Aerosol box placed.
Group II: No Aerosol BoxActive Control1 Intervention
The team will complete the resuscitation scenario without an Aerosol box placed.

Find a Location

Who is running the clinical trial?

KidSIM Simulation ProgramLead Sponsor
9 Previous Clinical Trials
1,830 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,388 Previous Clinical Trials
26,517,833 Total Patients Enrolled
Adam C Cheng, MDPrincipal InvestigatorUniversity of Calgary

Media Library

Aerosol Box Clinical Trial Eligibility Overview. Trial Name: NCT05868239 — N/A
Coronavirus Clinical Trial 2023: Aerosol Box Highlights & Side Effects. Trial Name: NCT05868239 — N/A
Aerosol Box 2023 Treatment Timeline for Medical Study. Trial Name: NCT05868239 — N/A
Coronavirus Research Study Groups: No Aerosol Box, Aerosol Box
~90 spots leftby Sep 2025